Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Teva
Queensland Health
McKinsey
Mallinckrodt
Citi
AstraZeneca
Chinese Patent Office
Argus Health

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,615,697

« Back to Dashboard

Summary for Patent: 4,615,697
Title: Bioadhesive compositions and methods of treatment therewith
Abstract:A controlled release treatment composition and method of use are disclosed. The composition includes a bioadhesive and an effective amount of a treating agent. The bioadhesive is a water-swellable, but water-insoluble, fibrous, cross-linked carboxy-functional polymer containing (a) a plurality of repeating units of which at least about 80 percent contain at least one carboxyl functionality, and (b) about 0.05 to about 1.5 percent cross-linking agent substantially free from polyalkenyl polyether.
Inventor(s): Robinson; Joseph R. (Madison, WI)
Assignee: Bio-Mimetics, Inc. (Lexington, MA)
Application Number:06/690,483
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 4,615,697
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;

Drugs Protected by US Patent 4,615,697

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,615,697

PCT Information
PCT FiledNovember 09, 1984PCT Application Number:PCT/US84/01827
PCT Publication Date:May 23, 1985PCT Publication Number: WO85/02092

International Family Members for US Patent 4,615,697

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0163696 ➤ Try a Free Trial
Germany 3486448 ➤ Try a Free Trial
Australia 565354 ➤ Try a Free Trial
Australia 3618484 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Teva
Merck
Daiichi Sankyo
Healthtrust
Boehringer Ingelheim
Express Scripts
US Army
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.